Showing results (1271-1280 of 1,587) with videos related to

Sort By:
Pageof 159
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 3, 1998
[Cancer-associated gene abnormalities and chemosensitivity]M Sakamoto, K Umayahara, H Sakamoto, et al.
Ageing Research Reviews|July 26, 2005
Medical bioremediation: prospects for the application of microbial catabolic diversity to aging and several major age-related diseasesAubrey D N J de Grey, Pedro J J Alvarez, Roscoe O Brady, et al.
Plos One|December 20, 2012
ATM suppresses SATB1-induced malignant progression in breast epithelial cellsEllen Ordinario, Hye-Jung Han, Saori Furuta, et al.
Nature Biotechnology|July 5, 2022
A multiplex implantable microdevice assay identifies synergistic combinations of cancer immunotherapies and conventional drugsZuzana Tatarova, Dylan C Blumberg, James E Korkola, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2016
Personal Genomic Testing for Cancer Risk: Results From the Impact of Personal Genomics StudyStacy W Gray, Sarah E Gollust, Deanna Alexis Carere, et al.
The Journal of Surgical Research|November 26, 2023
Bilateral Exchange: Enteral Nutrition Clinical Decision Making in Pediatric Surgery PatientsManisha B Bhatia, Cassandra M Anderson, Abdiwahab N Hussein, et al.
Genome Medicine|April 28, 2017
Activity of distinct growth factor receptor network components in breast tumors uncovers two biologically relevant subtypesMumtahena Rahman, Shelley M MacNeil, David F Jenkins, et al.
Molecular Cancer Research : MCR|August 9, 2011
Lrig1 is an estrogen-regulated growth suppressor and correlates with longer relapse-free survival in ERα-positive breast cancerSheryl R Krig, Seth Frietze, Catalina Simion, et al.
Cancer Research|May 6, 2004
An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arraysXiaojun Zhao, Cheng Li, J Guillermo Paez, et al.
The Journal of Clinical Investigation|June 15, 1996
Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipaseD M Stafforini, K Satoh, D L Atkinson, et al.
Pageof 159